44 related articles for article (PubMed ID: 32918090)
1. The Risk of Developing Long COVID in Patients With Inflammatory Bowel Diseases: Do Immunosuppressive Drugs Matter?
Bourgonje AR; Otten AT
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1971-1972. PubMed ID: 36642294
[No Abstract] [Full Text] [Related]
2. Biologic Choice Should Be Guided by Disease Severity Not Malignancy in Patients With Inflammatory Bowel Disease.
Zhou A; Srinivasan A; Vasudevan A
Clin Gastroenterol Hepatol; 2024 Mar; 22(3):670-672. PubMed ID: 37543103
[No Abstract] [Full Text] [Related]
3. Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group.
Al Tabaa Y; Casasnovas RO; Baillet C; Bachy E; Nicolas-Virelizier E; Schiano De Colella JM; Bailly C; Kanoun S; Guidez S; Gyan E; Gressin R; Morineau N; Ysebaert L; Le Gouill S; Tilly H; Houot R; Morschhauser F; Cartron G; Herbaux C
Blood Adv; 2023 Jul; 7(14):3735-3738. PubMed ID: 37067945
[No Abstract] [Full Text] [Related]
4. Al Tabaa Y, Casasnovas RO, Baillet C, et al. Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group. Blood Adv. 2023;7(14):3735-3738.
Blood Adv; 2024 Jun; 8(12):3225. PubMed ID: 38874949
[No Abstract] [Full Text] [Related]
5. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis.
Akiyama S; Hamdeh S; Micic D; Sakuraba A
Ann Rheum Dis; 2021 Mar; 80(3):384-391. PubMed ID: 33051220
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases.
Burke KE; Kochar B; Allegretti JR; Winter RW; Lochhead P; Khalili H; Colizzo FP; Hamilton MJ; Chan WW; Ananthakrishnan AN
Inflamm Bowel Dis; 2021 Jan; 27(2):155-161. PubMed ID: 33089863
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and Outcomes of COVID-19 Among Patients With Inflammatory Bowel Disease-A Danish Prospective Population-based Cohort Study.
Attauabi M; Poulsen A; Theede K; Pedersen N; Larsen L; Jess T; Rosager Hansen M; Verner-Andersen MK; V Haderslev K; Berg Lødrup A; Molazahi A; Neumann A; Wase A; Seidelin JB; Burisch J
J Crohns Colitis; 2021 Apr; 15(4):540-550. PubMed ID: 33035299
[TBL] [Abstract][Full Text] [Related]
8. Risk of adverse outcomes in inflammatory bowel disease patients infected with SARS-CoV-2: a systematic review and meta-analysis.
Chen L; Hu K; Cheng C; Hu Q; Zhang L; An T; Guo Y; Chen S; Duan G
Int J Colorectal Dis; 2022 Nov; 37(11):2277-2289. PubMed ID: 36271206
[TBL] [Abstract][Full Text] [Related]
9. Impact of biologics and small molecules for inflammatory bowel disease on COVID-19-related hospitalization and mortality: A systematic review and meta-analysis.
Alrashed F; Alasfour H; Shehab M
JGH Open; 2022 Apr; 6(4):241-250. PubMed ID: 35475207
[TBL] [Abstract][Full Text] [Related]
10. Current directions in IBD therapy: what goals are feasible with biological modifiers?
Sandborn WJ
Gastroenterology; 2008 Nov; 135(5):1442-7. PubMed ID: 18848556
[No Abstract] [Full Text] [Related]
11. SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting.
Siegel CA; Melmed GY; McGovern DP; Rai V; Krammer F; Rubin DT; Abreu MT; Dubinsky MC; ;
Gut; 2021 Apr; 70(4):635-640. PubMed ID: 33472895
[No Abstract] [Full Text] [Related]
12. Prevalence of Covid-19 Symptoms Among Inflammatory Bowel Disease Patients Treated with Biological Agents.
Conley TE; Probert C; Subramanian S
J Crohns Colitis; 2020 Dec; 14(12):1794-1795. PubMed ID: 32918090
[No Abstract] [Full Text] [Related]
13. SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy.
Selim R; Wellens J; Marlow L; Satsangi JJ
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):989. PubMed ID: 34655528
[No Abstract] [Full Text] [Related]
14. Uneventful Course in Patients With Inflammatory Bowel Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak in Northern Italy.
Norsa L; Indriolo A; Sansotta N; Cosimo P; Greco S; D'Antiga L
Gastroenterology; 2020 Jul; 159(1):371-372. PubMed ID: 32247695
[No Abstract] [Full Text] [Related]
15. Inflammatory Bowel Disease in the COVID-19 Pandemic: the Patients' Perspective.
Grunert PC; Reuken PA; Stallhofer J; Teich N; Stallmach A
J Crohns Colitis; 2020 Dec; 14(12):1702-1708. PubMed ID: 32564068
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
